发明名称 |
HERPES SIMPLEX VIRUS MUTANT ICP0 PROTEIN |
摘要 |
A mutant virus of herpes simplex virus type 1 (HSV-1) can include a mutant protein involved in replication so as to impair or inhibit replication of HSV-1. The mutant HSV-1 can have a mutation in at least one phosphorylation site of a protein involved in replication in order to inhibit phosphorylation of the site so as to prohibit or impair replication of HSV-1 and/or the clinical severity of HSV-1-mediated diseases. The mutant protein can be a mutant ICP0 that has reduced or inhibited posttranslational phosphorylation. The mutant HSV-1 and/or mutant ICP0 can be used in vaccines or other pharmaceutical preparations to treat, limit and/or prevent HSV-1 infection. The mutant HSV-1 and/or mutant ICP0 can also be used in screening and/or developing anti-HSV-1 agents.
|
申请公布号 |
US2009068215(A1) |
申请公布日期 |
2009.03.12 |
申请号 |
US20080167870 |
申请日期 |
2008.07.03 |
申请人 |
DAVIDO DAVID;SCHAFFER PRISCILLA |
发明人 |
DAVIDO DAVID;SCHAFFER PRISCILLA |
分类号 |
C07K14/035;A61K39/245;A61P31/22;C12N7/00 |
主分类号 |
C07K14/035 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|